Abstract
Curcuma longa Linn. is widely used for the treatment of disorders associated with inflammation and was evaluated for its safety and efficacy in the treatment of painful knee osteoarthritis (OA). This was a randomized, single blind, placebo-controlled trial. Total of 120 patients (37 males and 83 females) with primary knee OA received either placebo (400 mg twice daily) or NR-INF-02 (500 mg twice daily) or glucosamine sulphate (GS) (750 mg twice daily) alone or combination of NR-INF-02 and GS for 42 days. The efficacy was assessed during treatment period, on day 21 and day 42. The decrease in severity of pain symptom and function of affected knee as primary efficacy outcome measure was assessed by Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale, respectively. The clinical examination of affected joint was measured by an orthopaedic specialist and using a Clinician Global Impression Change (CGIC) scale. The analysis of post-treatment scores following administration of NR-INF-02 using VAS, WOMAC, and CGIC at each clinical visit showed significant decrease (p < 0.05) compared to placebo. NR-INF-02 treated group showed a significant (p < 0.01) decrease in use of rescue medication, along with clinical and subjective improvement compared to placebo. The tolerability and acceptability profile of NR-INF-02 was better during the trial period. The study demonstrates safety and efficacy of NR-INF-02 as a useful treatment option for patients with primary painful knee OA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed S, Anuntiyo J, Malemud CJ, Haqqi TM (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med 2:301–308
Badreldin H, Husnia M, Salwa A et al (2006) Some biological properties of curcumin: a review. Nat Prod Commun 1:509–521
Bellamy N (1989) Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. Semin Arthritis Rheum 18:14–17
Chainani-Wu N (2003) Safety and anti-inflammatory activity of Curcumin: a component of turmeric (Curcuma longa). J Altern Compliment Medicine 9:161–168
Chopra A, Lavin P, Patwardhan B, Chitre D (2004) A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 10:236–245
Clegg DO, Reda DJ, Harris CL et al (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354:795–808
Felson DT (2006) Clinical practice. Osteoarthritis of the knee. N Engl J Med 354:841–848
Felson DT (2008) Osteoarthritis. In: Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, Loscalzo J (Eds). Harrison’s principles of internal medicine, New York, McGraw-Hill, pp 2158–2164
Fries JF, Williams CA, Bloch DA (1991) The relative toxicity of nonsteroidal antiinflammatory drugs. Arthritis Rheum 34:1353–1360
Gomis DB, Tamayoa DM, Alonso JM (2001) Determination of monosaccharides in cider by reversed-phase liquid chromatography. Anal Chim Acta 436:173–180
Gonda R, Tomoda M, Ohara N, Takada K (1993) Arabinogalactan core structure and immunological activities of ukonan C, an acidic polysaccharide from the rhizome of Curcuma longa. Biol Pharm Bull 16:235–238
Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M et al (2007) Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum 56:555–567
Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14:141–153
Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502
Khanna D, Sethi G, Ahn KS et al (2007) Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 3:344–351
Kulkarni RR, Patki PS, Jog VP et al (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33:91–95
Kulkarni Chanda, Leena A, Lohit K et al (2012) A randomized comparative study of safety and efficacy of immediate release glucosamine HCL and glucosamine HCL sustained release formulation in the treatment of knee osteoarthritis: A proof of concept study. J Pharmacol Pharmacotherapeut 3:48–54
Ramberg JE, Nelson ED, Sinnott RA (2010) Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J 9:54
Sharma L (2003) Proprioception in osteoarthritis. In: Brandt K, Doherty M, Lohmander S (eds) Osteoarthritis. Oxford University Press, New York, pp 172–177
Sharma M, Swami H, Bhatia V et al (2007) An epidemiological study of correlates of osteo-arthritis in geriatric population of UT Chandigarh. Indian J Commun Med 32:77–78
Trnovec T, Hrmová M (1993) Immunomodulator polysaccharides: chemistry, disposition and metabolism. Biopharm Drug Dispos 14:187–198
Wandel S, Juni P, Tendal B et al (2010) Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. Br Med Assoc 341:c4675
Acknowledgments
The authors wish to gratefully acknowledge Natural Remedies Private Limited, Bangalore, India, for providing test medications for this trial and to Mr. Devesh Mishra, lecturer, Division of Clinical Pharmacology, St. John’s Medical College, Bangalore, for his assistance in preparation of protocol in the initial part of this clinical trial.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Madhu, K., Chanda, K. & Saji, M.J. Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacol 21, 129–136 (2013). https://doi.org/10.1007/s10787-012-0163-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-012-0163-3